Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Incomplete Revascularization Does Not Mean the Same Thing for All Patients

Several studies show that patients with multivessel lesions who undergo angioplasty with incomplete revascularization experience more events, including higher mortality, than a cohort of patients who have undergone complete revascularization.La revascularización incompleta no tiene el mismo significado en todos los pacientes

In most cases, the analysis was dichotomic (complete vs. incomplete revascularization), but more recent studies show that there may be a gradient, a continuum, in which not all patients with incomplete revascularization are equal. The study herein discussed went beyond this and looked for specific vessels that seem to be more important, and the stenosis threshold from which different outcomes might be expected.


Read also: Five-Year Outcomes for Appendage Closure”.


New York’s angioplasty database was used to examine mortality (mean follow-up, 3.4 years) as a function of the number of vessels that were not revascularized, the stenosis in those vessels, and how compromised the proximal left anterior descending artery was after controlling for other factors associated with mortality.

 

This study included 41,639 patients with multivessel disease who underwent angioplasty between 2010 and 2012.

 

Incomplete revascularization was very common (78% among patients admitted with ST-segment elevation myocardial infarction and 71% among patients with non-ST-segment elevation acute coronary syndromes and stable coronary disease). Patients with incomplete revascularization in a vessel with at least 90% stenosis were at higher risk than other patients with incomplete revascularization. This was different for patients with ST-elevation myocardial infarction (17.18% vs. 12.86%; hazard ratio [HR]: 1.16; 95% confidence interval [CI]: 0.99-1.37), but significant among all other patients (17.71% vs. 12.96%; HR: 1.15; 95% CI: 1.07-1.24).


Read also: New FFR Measuring Device to Guide Coronary Revascularization with Our Preferred Wire”.


Similarly, patients with incomplete revascularization in 2 or more vessels had higher mortality than patients with complete revascularization and patients with incomplete revascularization in only one vessel.

 

Results among patients with no revascularization of the proximal left anterior descending artery vessel were anything but surprising: they had higher mortality than all other patients with incomplete revascularization, regardless of their clinical syndrome.

 

More than 20% of all patients who underwent angioplasty had incomplete revascularization of 2 or more vessels and more than 30% had at least one lesion with more than 90% stenosis.

 

Conclusion

Patients with incomplete revascularization are at higher risk of mortality in the following cases:

  • If they have a lesion with more than 90% stenosis that has not been revascularized.
  • If 2 or more vessels are left without revascularization.
  • If the vessel without revascularization is the proximal anterior descending artery.

 

Editorial

The first results of this database analysis showed that in an extremely high percentage of patients with angioplasty and incomplete revascularization (96%) physicians directly did not attempt complete revascularization.

 

This is important information, since it allows us to reduce drastically the risk for these patients. Now, we have a better idea of which lesions we should unavoidably revascularize (or, at least, make an attempt).

 

Original title: Association of Coronary Vessel Characteristics with Outcome in Patients with Percutaneous Coronary Interventions with Incomplete Revascularization.

Reference: Edward L. Hannan et al. JAMA Cardiol. 2017 Dec 27. Epub ahead of print.


Suscríbase a nuestro newsletter semanal

Reciba resúmenes con los últimos artículos científicos

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

 

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...